BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 8161625)

  • 1. Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review.
    John CC
    Clin Infect Dis; 1994 Feb; 18(2):188-93. PubMed ID: 8161625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins.
    Tan TQ; Schutze GE; Mason EO; Kaplan SL
    Antimicrob Agents Chemother; 1994 May; 38(5):918-23. PubMed ID: 8067771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of penicillin-resistant pneumococcal meningitis.
    Schwartz MT; Tunkel AR
    Zentralbl Bakteriol; 1995 Jan; 282(1):7-12. PubMed ID: 7734832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis.
    Friedland IR; Shelton S; Paris M; Rinderknecht S; Ehrett S; Krisher K; McCracken GH
    Pediatr Infect Dis J; 1993 Mar; 12(3):196-200. PubMed ID: 8451095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use.
    Arditi M; Mason EO; Bradley JS; Tan TQ; Barson WJ; Schutze GE; Wald ER; Givner LB; Kim KS; Yogev R; Kaplan SL
    Pediatrics; 1998 Nov; 102(5):1087-97. PubMed ID: 9794939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro bactericide activity of different antibiotic combinations to Streptococcus pneumoniae resistant to penicillin and cefotaxime].
    Tubau F; Liñares J; Ardanuy C; Martínez-Lacasa J; Fernández A; Cabellos C; Fernández-Viladrich P; Martín R
    Enferm Infecc Microbiol Clin; 1996 Dec; 14(10):590-5. PubMed ID: 9053000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bactericidal activity of cefotaxime, desacetylcefotaxime, rifampin, and various combinations tested at cerebrospinal fluid levels against penicillin-resistant Streptococcus pneumoniae.
    Cormican MG; Erwin ME; Jones RN
    Diagn Microbiol Infect Dis; 1995; 22(1-2):119-23. PubMed ID: 7587024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of ceftriaxone, vancomycin and rifampicin alone and combined in an experimental model of meningitis caused by highly cephalosporin-resistant Streptococcus pneumoniae ATCC 51916.
    Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Fernández Viladrich P; Gudiol F
    J Antimicrob Chemother; 2005 Nov; 56(5):979-82. PubMed ID: 16174686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of penicillin-resistant pneumococcal meningitis and antibiotic susceptibility of Streptococcus pneumoniae isolated from children].
    Himi K; Miyamoto S; Ohshimi H; Kuroki H; Ishikawa N; Yamazaki T; Namba M; Suzuki H; Uehara S; Niimi H
    Kansenshogaku Zasshi; 1990 Jun; 64(6):725-33. PubMed ID: 2401818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penicillin- and Cephalosporin-Resistant Pneumococcal Meningitis: Treatment in the Real World and in Guidelines.
    Cabellos C; Guillem L; Pelegrin I; Tubau F; Ardanuy C; Gudiol F; Ariza J; Viladrich PF
    Antimicrob Agents Chemother; 2022 Dec; 66(12):e0082022. PubMed ID: 36326246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penicillin and ceftriaxone susceptibility of Streptococcus pneumoniae isolated from cerebrospinal fluid of children with meningitis hospitalized in a tertiary hospital in Israel.
    Waisbourd-Zinman O; Bilavsky E; Tirosh N; Samra Z; Amir J
    Isr Med Assoc J; 2010 Apr; 12(4):225-8. PubMed ID: 20803882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial therapy of experimental meningitis caused by Streptococcus pneumoniae strains with different susceptibilities to penicillin.
    McCracken GH; Sakata Y
    Antimicrob Agents Chemother; 1985 Feb; 27(2):141-5. PubMed ID: 3845793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for cephalosporin-resistant Streptococcus pneumoniae with the Kirby-Bauer disk susceptibility test.
    Friedland IR; Shelton S; McCracken GH
    J Clin Microbiol; 1993 Jun; 31(6):1619-21. PubMed ID: 8315005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci.
    Viladrich PF; Gudiol F; Liñares J; Rufi G; Ariza J; Pallares R
    Am J Med; 1988 May; 84(5):839-46. PubMed ID: 3364443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro killing of penicillin-susceptible, -intermediate, and -resistant strains of Streptococcus pneumoniae by cefotaxime, ceftriaxone, and ceftizoxime: a comparison of bactericidal and inhibitory activity with achievable CSF levels.
    Stratton CW; Aldridge KE; Gelfand MS
    Diagn Microbiol Infect Dis; 1995; 22(1-2):35-42. PubMed ID: 7587048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penicillin-resistant pneumococcal meningitis in Israel.
    Steinberg T; Rachmel A; Samra Z; Ashkenazi S
    Isr J Med Sci; 1997 Nov; 33(11):757-9. PubMed ID: 9434816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of penicillin-resistant pneumococci to eighteen antimicrobials: implications for treatment of meningitis.
    Tweardy DJ; Jacobs MR; Speck WT
    J Antimicrob Chemother; 1983 Aug; 12(2):133-9. PubMed ID: 6555189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-kill studies of antimicrobial combinations including cefotaxime, ceftriaxone, vancomycin and meropenem against cephalosporin-resistant Streptococcus pneumoniae.
    Kim BN; Woo JH; Kim YS; Ryu J; Kim MN; Pai CH
    Chemotherapy; 2000; 46(5):303-8. PubMed ID: 10965094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meropenem alone and in combination with vancomycin in experimental meningitis caused by a penicillin-resistant pneumococcal strain.
    Gerber CM; Cottagnoud M; Neftel KA; Täuber MG; Cottagnoud P
    Eur J Clin Microbiol Infect Dis; 1999 Dec; 18(12):866-70. PubMed ID: 10691197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality indicators in pneumococcal meningitis: therapeutic implications.
    Erdem H; Elaldi N; Öztoprak N; Sengoz G; Ak O; Kaya S; Inan A; Nayman-Alpat S; Ulu-Kilic A; Pekok AU; Gunduz A; Gozel MG; Pehlivanoglu F; Yasar K; Yılmaz H; Hatipoglu M; Cicek-Senturk G; Akcam FZ; Inkaya AC; Kazak E; Sagmak-Tartar A; Tekin R; Ozturk-Engin D; Ersoy Y; Sipahi OR; Guven T; Tuncer-Ertem G; Alabay S; Akbulut A; Balkan II; Oncul O; Cetin B; Dayan S; Ersoz G; Karakas A; Ozgunes N; Sener A; Yesilkaya A; Erturk A; Gundes S; Karabay O; Sirmatel F; Tosun S; Turhan V; Yalci A; Akkoyunlu Y; Aydın E; Diktas H; Kose S; Ulcay A; Seyman D; Savasci U; Leblebicioglu H; Vahaboglu H
    Int J Infect Dis; 2014 Feb; 19():13-9. PubMed ID: 24211227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.